Greenstreet Yvonne - Insider Transactions
Insider Type
individual
Companies
1
Average
661,707
Total Txns
86
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 28 | -28 | 0.00 | 14,864,802.46 | -14,864,802.46 |
| 2025 | 0 | 58 | -58 | 0.00 | 42,041,967.22 | -42,041,967.22 |
| Total: | 0 | 86 | 10 | 0.00 | 56,906,769.68 | -56,906,769.68 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
450.81 USD |
1,642 Sold |
740,230 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
449.79 USD |
758 Sold |
340,941 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
999 Sold |
453,316 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
451.86 USD |
1,010 Sold |
456,379 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
447.92 USD |
171 Sold |
76,594 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
452.69 USD |
2,029 Sold |
918,508 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
999 Sold |
453,316 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
999 Sold |
453,316 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
448.77 USD |
548 Sold |
245,926 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
446.53 USD |
350 Sold |
156,286 USD |
01/10/2025 | 02/10/2025 |